Amplification of the cyclin D1 gene has not only been associated with multi-drug resistance in MM [76] but a polymorphism in the gene is a risk factor for t(11;14)(q13;q32) MM [77]. The gene discussed is CCND1; the disease is Miyoshi myopathy.